Evidence map›Paper›PMID 30682456›Full record

ArticleThe Journal of allergy and clinical immunology2019

Nanoallergen platform for detection of platin drug allergies.

Peter E Deak, Baksun Kim, Ather Adnan, Marina Labella, Leticia De Las Vecillas, Mariana Castells, Basar Bilgicer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of allergy and clinical immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Determination of immunogenic epitopes in major house dust mite allergen, Der p 2, via nanoallergens.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Cephalosporin Allergy: Current Understanding and Future Challenges.The journal of allergy and clinical immunology. In practice
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Peter E DeakDepartment of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, Ind.
Baksun KimDepartment of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, Ind.
Ather AdnanDivision of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.
Marina LabellaDivision of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.
Leticia De Las VecillasDivision of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass; Department of Allergy, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain.
Mariana CastellsDivision of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.
Basar BilgicerDepartment of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, Ind; Advanced Diagnostics and Therapeutics, University of Notre Dame, Notre Dame, Ind; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Ind. Electronic address: bbilgicer@nd.edu.

Funding

Designing Selective Inhibitors of IgE-mediated Mast Cell DegranulationR01AI108884 · NIAID · UNIVERSITY OF NOTRE DAME · PI BILGICER, ZIHNI BASAR · 2015 to 2024
$3.6M
NIAID NIH HHS R01 AI108884
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NanoparticlesAgedAllergensAntineoplastic AgentsCarboplatinCell LineDesensitization, ImmunologicDrug HypersensitivityFemaleHumansImmunoglobulin ELiposomesMaleMiddle AgedOxaliplatinSkin TestsAllergensAntineoplastic AgentsCarboplatinImmunoglobulin ELiposomesOxaliplatin

Identifiers

PMID30682456
PMCPMC6608568

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.